anti-nuclear factor
antinucleosome
Ab
antinucleotide
monoantibody
-mab
reagin
guselkumab
muromonab
antipolyvalent
-ab
gevokizumab
antinucleoside
abagovomab
olaratumab
tislelizumab
pidilizumab
satetraxetan
ravulizumab
brolucizumab
radioimmunoreactivity
immunocharacterize
dinutuximab
pozelimab
solitomab
zenocutuzumab
vanucizumab
retifanlimab
sasanlimab
immunomolecule
sintilimab
toripalimab
ziltivekimab
antiustekinumab
antitheta
countercorrelated
antisubstance
antiphospholipid
polyvalent
-toxa-
immunoprobe
radioimmunoprecipitate
radioimmunoelectrophoresis
defense mechanism
bispecific
cergutuzumab
antiplasma
chromobody
antiantibody
radiocompetitive